Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
  1. 4 Shares withheld for taxes Chief Financial Officer gave up 703 shares (to pay taxes)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Planned sale President sold 53,336 shares at $51.37 ($2,739,870)
  4. 4 Planned sale Chief Legal Officer sold 3,471 shares at $50.00 ($173,550)
  5. 4 Shares withheld for taxes Chief Financial Officer gave up 5,705 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Financial Officer gave up 1,197 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Legal Officer gave up 1,047 shares (to pay taxes)
  8. 4 Shares withheld for taxes President gave up 4,488 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Financial Officer gave up 533 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Legal Officer gave up 533 shares (to pay taxes)
  11. 4 Shares withheld for taxes President gave up 990 shares (to pay taxes)
  12. 4 Open-market sale Director sold 9,263 shares at $46.84 ($433,879)
  13. 4 Planned sale President sold 53,336 shares at $48.40 ($2,581,462)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 54 · 1,067 filings